IP Infusion extends OcNOS to Broadcom Qumran3 chipset family
IP Infusion announced OcNOS support for Broadcom Qumran3-based open platforms, expanding its operating system compatibility to 50+ hardware platforms and enabling unified network environments across multiple operator domains.
How Oyticker scores a story: impact and confidence describe the information, not a probability that a price moves.
What happened
IP Infusion announced at SCTE TechExpo 2026 that its OcNOS network operating system will support open platforms based on the Broadcom Qumran3 family of chipsets. This extends OcNOS compatibility to over 50 open hardware platforms and targets fiber, cable, and mobile operators across Access, Aggregation, Transport and Core Network domains.
Why it matters
Broadening OcNOS support to Qumran3 reduces operator switching costs and vendor lock-in by enabling a single NOS across diverse network layers and operator types. This increases addressable market for IP Infusion's software and strengthens Broadcom's ecosystem value proposition for open RAN and disaggregated networking deployments.
Market transmission
First-order: expanded TAM for IP Infusion OcNOS licensing and support services; increased stickiness of Broadcom Qumran3 chipsets in open networking. Second-order: accelerates operator migration from proprietary to open architectures, potentially pressuring legacy networking vendors; supports broader telecom capex efficiency and software-defined infrastructure adoption.
What to watch
Operator adoption rates of OcNOS on Qumran3 platforms; competitive responses from other NOS vendors (e.g., Nokia, Cisco); Broadcom's Qumran3 design-win announcements; IP Infusion customer wins in fiber/cable/mobile segments.
Source:Business Wire
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.